GEHC vs TEM
GEHC: GE HealthCare is a leading global medical technology provider delivering advanced diagnostic imaging, clinical systems, and intelligent digital solutions to healthcare providers worldwide. TEM: Tempus AI leverages a massive library of multimodal clinical and molecular data to power AI-driven precision medicine for patients and researchers.
Side-by-side fundamentals
| Metric | GEHC | TEM | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $68.02 | $43.87 | |
| Market cap as of 2026-08-03 | $30.9B | $7.9B | |
| P/E as of 2026-08-03 | 16.30 | n/a | |
| PEG as of 2026-08-03 | 2.30 | -1.42 | TEM lower |
| Net margin as of 2026-08-03 | +9.1% | -22.2% | GEHC higher |
| Gross margin as of 2026-08-03 | +39.1% | +63.4% | TEM higher |
| Operating margin as of 2026-08-03 | +12.6% | -20.6% | GEHC higher |
| ROE as of 2026-08-03 | +18.8% | -70.2% | GEHC higher |
| ROA as of 2026-08-03 | +5.3% | -14.6% | GEHC higher |
| Debt / equity as of 2026-08-03 | 0.95 | 2.96 | GEHC lower |
| Revenue growth (YoY) as of 2026-08-03 | +6.0% | +69.8% | TEM higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +58.3% | TEM higher |
| Dividend yield as of 2026-08-03 | +0.2% | n/a | |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-08-03 | 1.06 | 2.70 | |
| 1-year return as of 2026-07-31 close | -4.6% | -22.5% | GEHC higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.